Psychiatrist.com Home    Keyword Search

Close [X]

Search Our Sites

Enter search terms below (keywords, titles, authors, or subjects). Then select a category to search and press the Search button. All words are assumed to be required. To search for an exact phrase, put it in quotes. To exclude a term, precede it with a minus sign (-).

Keyword search:

Choose a category:

Choosing the appropriate category will greatly improve your chances of finding the best match.

All files at our sites: J Clin Psychiatry, Primary Care Companion, CME Institute, and MedFair

Search materials from our journals:

Abstracts from The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements

PDFs of the full text of The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements (Net Society Platinum [paid subscribers])

PDFs of the full text of The Primary Care Companion to The Journal of Clinical Psychiatry, 1999–present

Search CME offerings:

CME Institute, including CME from journals , supplements, and Web activities for instant CME credit (Net Society Gold [registered users]); also includes information about our CME program

CME activities from regular issues of The Journal of Clinical Psychiatry (Net Society Gold [registered users])

CME Supplements from The Journal of Clinical Psychiatry (Net Society Gold [registered users])
The American Society of Clinical Psychopharmacology

The Journal of Clinical Psychiatryis the official journal of the American Society of Clinical Psychopharmacology (ASCP). Each month, the ASCP contributes "ASCP Corner" to the Journal. The Corner contains short evidence-based discussions on clinical psychopharmacology and periodically contains news of the Society and announcements of Society meetings and activities.

Available ASCP Corners

2008

The Search for Knowledge: Developing the American Psychiatric Association's Practice Guideline for Major Depressive Disorder.

Alan J. Gelenberg

[PDF]

Are Nutritional Supplements Ready for Prime Time?

David Mischoulon and Maurizio Fava

[PDF]

Are Antidepressants Effective? What’s a Clinician to Think?

J. Craig Nelson, Michael E. Thase, and Arif Khan

[PDF]

Antipsychotic Polypharmacy, Part 2: Why Use 2 Antipsychotics When 1 Is Not Good Enough?

Christoph U. Correll

[PDF]

Antipsychotic Polypharmacy, Part 1: Shotgun Approach or Targeted Cotreatment?

Christoph U. Correll

[PDF]

What Constitutes Evidence-Based Pharmacotherapy for Bipolar Disorder? Part 2: Complex Presentations and Clinical Context

Joseph F. Goldberg

[PDF]

Balancing Risks: Dosing Strategies for Antidepressants Near the End of Pregnancy

Laura J. Miller, Jeffrey R. Bishop, James H. Fischer, Stacie E. Geller, and Carol Macmillan

[PDF]

State of the Society.

[PDF]

2007

What Constitutes Evidence-Based Pharmacotherapy for Bipolar Disorder? Part 1: First-Line Treatments.

Joseph F. Goldberg

[PDF]

Teaching and Practicing Psychopharmacology

John M. Kane

[PDF]

Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 2: Methodological Considerations

Worried Sick: Antidepressants, Stress, and Inflammation

R.Bruce Lydiard, Ph.D., M.D.

[PDF]

Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 2: Methodological Considerations

Christoph U. Correll, M.D.

[PDF]

Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 1: Challenges and Developments

Christoph U. Correll, M.D.

[PDF]

Dual Dependency on Cocaine and Alcohol in Opiate Addicts: Treatment Options

Tracie Gardner, Ph.D., and Thomas Kosten, M.D.

[PDF]

Pharmacoepidemiology: Recent Findings and Challenges for Child and Adolescent Psychopharmacology

Julie Magno Zito, Ph.D.

[PDF]

Psychopharmacology in the Emergency Room

Michael D. Jibson, M.D., Ph.D.

[PDF]

Psychopharmacologic Treatment Response of HIV-Infected Patients to Antipsychotic Medications

Dinesh Singh, M.B.Ch.B., M.Med. (Psych), F.C.Psych.; and Karl Goodkin, M.D., Ph.D., F.A.P.A.

[PDF]

Choice of Antipsychotic in HIV-Infected Patients

Dinesh Singh, M.B.Ch.B., M.Med. (Psych),F.C.Psych.; and Karl Goodkin, M.D., Ph. D., F.A.P.A.

[PDF]

The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 2: Long Term Treatement

Leslie Citrome, M.D., M.P.H.

[PDF]

The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 1: Acute Treatement

Leslie Citrome, M.D., M.P.H.

[PDF]

2006

Primary Care Pitfalls for the Psychiatrist Psychopharmacologist

James W. Thompson, M.D., M.P.H.

[PDF]

Measurement-Based Psychiatry: Definitions of Response, Remission, Stability, and Relapse in Schizophrenia

Stefan Leucht, M.D., and John M. Kane, M.D.

[PDF]

Combining Pharmacotherapy With Psychotherapeutic Management: Guidelines for Integration

Ira D. Glick, M.D.

[PDF]

Buprenorphine: Reflections of an Addictions Psychiatrist

Jeffrey Selzer, M.D.

[PDF]

FDA Post-Marketing Safety Decisions

Donald F. Klein, M.D.

[PDF]

ASCP Administers 10th Certification Exam

ASCP Examination Committee

[PDF]

Female Sexual Dysfunctions: What Controversy?

Anita H. Clayton, M.D.

[PDF]

Commentary on the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)

John M. Kane, M.D.

[PDF]

Novel Transdermal Delivery Formulation of the Monoamine Oxidase Inhibitor Selegiline Nearing Release for Treatment of Depression

Michael E. Thase, M.D.

[PDF]

Use of Atypical Antipsychotics: Observations From Clinical Practice

Scott A. Spier, M.D.

[PDF]

Complex Chemical Concoctions

James W. Jefferson, M.D.

[PDF]

Real-Life Switching Strategies With Second-Generation Antipsychotics

Christoph U. Correll, M.D.

[PDF]

2005

Real-Life Dosing With Second-Generation Antipsychotics

Christoph U. Correll, M.D.

[PDF]

Sexual Function and Dysfunction During Treatment With Psychotropic Medications

Richard Balon, M.D.

[PDF]

Metabolic Side Effects of Second-Generation Antipsychotics in Children and Adolescents: A Different Story?

Christoph U. Correll, M.D.

[PDF]

Gender Differences in Clinical Psychopharmacology

Anita H. Clayton, M.D.

[PDF]

Increased Risk of Cerebrovascular Adverse Events and Death in Elderly Demented Patients Treated With Atypical Antipsychotics: What’s a Clinician to Do?

J. Craig Nelson, M.D.

[PDF]

Challenges and Opportunities in Teaching Psychopharmacology During Residency Training

Sidney Zisook, M.D.; Ira Glick, M.D.; and David A. Goldberg, M.D.

[PDF]

Cultural Competence in Clinical Psychopharmacology

James W. Thompson, M.D., M.P.H.

[PDF]

Reading Reports of Clinical Trial Results

John M. Kane, M.D.

[PDF]

From the President

John M. Kane, M.D.

[PDF]